Beyond its direct impact on treating red blood cell disorders, the findings suggest that metabolic features such as glutamine–to–glutamate ratios can be used as biomarkers for many other diseases.

This helped the researchers create a drug-like molecule that could stop bicarbonate transport, which might potentially be used for new treatments for blood disorders.

The 2024 ASH Annual Meeting showcased advancements in red blood cell disorders, including anemia, sickle cell disease, and thalassemia, with a focus on innovative treatments and emerging technologies.

Red blood cells, long thought to be passive bystanders in the formation of blood clots, actually play an active role in ...

Red blood cell tests may include a hemoglobin test or hematocrit test; a low count or percentage may be caused by a type of anemia. White blood cells are an important part of the immune response.

Researchers from the University of Pennsylvania found that red blood cells, not just platelets, actively contribute to the ...

Combining lasers with a principle discovered by Alexander Graham Bell over 100 years ago, researchers have developed a new way to collect high-resolution information about the shape of red blood ...

Researchers at Northwell’s Feinstein Institutes for Medical Research have received a $6 million grant from the National Institutes of Health to study red blood cell disorders, the health system ...

Straight to the Marrow Genetic blood disorders are brutal. Sickle cell disease aside, others, such as beta-thalassemia, reduce the ability of red blood cells to carry oxygen, resulting in severe ...

Sickle cell disease is inherited and affects the body’s red blood cells. Healthy red blood cells are round like an O and can move easily through blood vessels.

Sickle cell disease disproportionately affects people in the U.S. who are Black. Patient blood recipients finding a good match can mean everything.